Market Place
Sourcing Support
IPAB stays revocation of Novartis’ patent on anti-cancer drug Ceritinib
12 Aug 2020 //
PHARMABIZ
NICE final guidance backs Pfizer`s Lorviqua
13 May 2020 //
PHARMA TIMES
Novartis, Pfizer, AZ and more hand China 50%-plus cancer drug discounts
11 Oct 2018 //
FIERCE PHARMA
Preliminary NICE ‘no’ for Takeda’s Alunbrig
03 Oct 2018 //
PHARMA TIMES
Takeda`s Alunbrig trounces Pfizer drug in bid for earlier ALK lung cancer use
26 Sep 2018 //
FIERCE PHARMA
Bristol-Myers to sell Opdivo in China at half-price: report
22 Aug 2018 //
FIERCE PHARMA
Pfizer files third-gen ALK inhibitor for lung cancer
14 Feb 2018 //
PMLIVE
First-line use of lung cancer drug Zykadia gets NHS nod
25 Jan 2018 //
PHARMA TIMES
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
06 Jan 2018 //
FIERCE PHARMA
Star drugs like BMS’ Opdivo, AstraZeneca’s Lynparza will get speedy OKs in China
03 Jan 2018 //
END POINTS
Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer
05 Jun 2017 //
FIERCE PHARMA
Roche announces FDA approval of companion diagnostic to identify ALK-positive
01 Jun 2017 //
PR NEWSWIRE
FDA grants approval for Roche`s ALK test as CDx for Zykadia
01 Jun 2017 //
BIOSPECTRUM
Novartis AG to Lay Off 250 Nationwide, With 204 , New Jersey U.S. Headquarters
25 May 2017 //
BIOSPACE
Novartis` Zykadia prepped to take on Xalkori in Europe
23 May 2017 //
PMLIVE
Novartis` (NVS) Lung Cancer Drug Gets Positive CHMP Opinion
22 May 2017 //
Novartis` Zykadia scores priority review and breakthrough designation from FDA
24 Feb 2017 //
PHARMAFILE
Novartis announces positive results from phIII ASCEND-4 study of Zykadia
07 Dec 2016 //
PHARMABIZ
Novartis adds new chemo-topping data to Zykadia marketing arsenal
12 Oct 2016 //
FIERCE PHARMA
Pfizer widens Xalkori`s reach with another targeted lung cancer approval
14 Mar 2016 //
FIERCE PHARMA MARKETING
Pharma Giant AZN in Advanced Talks to Buy Acerta Pharma for $5Bn+
15 Dec 2015 //
BIOSPACE
Roche challenges hometown rival Novartis with new targeted med Alecensa
14 Dec 2015 //
FIERCE PHARMA MARKETING
Five medicines cleared for use by NHS Scotland
07 Dec 2015 //
PHARMATIMES
Novartis launches lung cancer drug, but fears limited access
28 Nov 2015 //
PHARMATIMES
AstraZeneca`s Tagrisso to cost $12,750 for a month`s supply
18 Nov 2015 //
REUTERS
FDA grants Roche’s alectinib priority review for lung cancer
10 Sep 2015 //
PM LIVE
Novartis CEO: Payers not sold on performance pricing yet, but that`ll change
08 Sep 2015 //
FIERCE PHARMA
Novartis` Zykadia (Ceritinib) Approved in Europe For Lung Cancer
05 Jun 2015 //
EMA
Novartis’ Zykadia (Ceritinib) Approved In Europe For ALK and NSCLC
09 May 2015 //
NOVARTIS
Pfizer, Merck KGaA suit up for Xalkori marketing wave
09 Apr 2015 //
FIERCE PHARMA MARKETING
Novartis Cancer Pill Makes It Onto UK Early Access List
01 Apr 2015 //
PMLIVE
FDA Continues to Lead in Precision Medicine
23 Mar 2015 //
FDA VOICE
Zykadia Recommended For Approval In Advanced Non Small Cell Lung Cancer
27 Feb 2015 //
EMA
